Rocket One Inc. SEC filings

Filings

1. PRE 14ARocket One Inc.RKTOOct 2

   Rocket One Inc. announces 2026 annual meeting

   • Annual meeting on December 17, 2026
   • Virtual meeting via webcast
   • Six proposals including director election and stock split
2. 8-KRocket One Inc.HOTHSep 25

   Current report

3. 8-KRocket One Inc.RKTOSep 22

   Current report

4. 10-QRocket One Inc.HOTHAug 14

   Quarterly report

5. 8-KRocket One Inc.RKTOAug 11

   Current report

6. 8-KRocket One Inc.HOTHJul 31

   Current report

7. 424B5Rocket One Inc.HOTHJul 31

   Securities offering

8. 8-KRocket One Inc.HOTHJul 21

   Current report

9. 8-KRocket One Inc.RKTOJun 25

   Current report

10. 8-KRocket One Inc.HOTHJun 3

    Current report

11. 8-KRocket One Inc.HOTHJun 3

    Current report

12. 424B5Rocket One Inc.HOTHJun 3

    Securities offering

13. 8-KRocket One Inc.HOTHJun 2

    Current report

14. 4Rocket One Inc.HOTHMay 28

    5 insider filings

    David Sarnoff, insider filing for HOTH

    Show all 5

    • 4Insider filing for HOTHMay 28
    • 4Insider filing for HOTHMay 28
    • 4Insider filing for HOTHMay 28
    • 4Insider filing for HOTHMay 28
    • 4Insider filing for HOTHMay 28

    David Sarnoff, reporting

15. 8-KRocket One Inc.HOTHMay 28

    Current report

16. 424B5Rocket One Inc.HOTHMay 27

    Securities offering

17. 8-KHoth Therapeutics, Inc.HOTHMay 27

    Current report

18. 8-KHoth Therapeutics, Inc.HOTHMay 21

    Current report

19. 10-QHoth Therapeutics, Inc.HOTHMay 15

    Quarterly report

20. 8-KHoth Therapeutics, Inc.HOTHMay 6

    Current report

21. 8-KHoth Therapeutics, Inc.HOTHMay 4

    Current report

22. 8-KHoth Therapeutics, Inc.HOTHApr 16

    Current report

23. 424B5Hoth Therapeutics, Inc.HOTHApr 16

    Securities offering

24. 8-KHoth Therapeutics, Inc.HOTHApr 2

    Current report

25. 424B5Hoth Therapeutics, Inc.HOTHApr 2

    Securities offering

26. 10-KHoth Therapeutics, Inc.HOTHMar 27

    Annual report

27. 8-KHoth Therapeutics, Inc.HOTHJan 16

    Current report

28. EFFECTHoth Therapeutics, Inc.HOTHDec 5, 2025

    Registration declared effective

29. 424B5Hoth Therapeutics, Inc.HOTHNov 13, 2025

    Hoth Therapeutics, Inc. (HOTH) has filed a 424B5 prospectus supplement to raise up to $4.8 million through a public offering. The filing provides details on the company's capital raise, which will support the ongoing development of its pharmaceutical pipeline and clinical…

30. 10-QHoth Therapeutics, Inc.HOTHNov 12, 2025

    Quarterly report

Older filings on EDGAR